Proteins

Vatalanib succinate.

Vatalanib succinate.

Mouse anti Human VAV1 Antibody, Monoclonal (1582CT802.383.58), could be used for WB and so on.Application· WB: 1/4000 Protein FunctionCouples tyrosine kinase signals with the activation of the Rho/Rac GTPases, thus leading to cell differentiation

Mouse anti Human VAV1 Antibody, Monoclonal (1582CT802.383.58), could be used for WB and so on.Application· WB: 1/4000 Protein FunctionCouples tyrosine kinase signals with the activation of the Rho/Rac GTPases, thus leading to cell differentiation

Mouse anti Human VAV1 Antibody, Monoclonal (1582CT802.383.58), could be used for WB and so on.Application· WB: 1/4000 Protein FunctionCouples tyrosine kinase signals with the activation of the Rho/Rac GTPases, thus leading to cell differentiation

Mouse anti Human VAV1 Antibody, Monoclonal (1582CT802.383.58), could be used for WB and so on.Application· WB: 1/4000 Protein FunctionCouples tyrosine kinase signals with the activation of the Rho/Rac GTPases, thus leading to cell differentiation

General DescriptionVBS⁺⁺ is like the traditional buffer used in complement assays (GVB⁺⁺) but it lacks the carrier protein gelatin often used in these assays. GVB may be replaced with VBS if gelatin is undesirable or may interfere with the assays.

VGX100 (anti-VEGFC) is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis.

VGX100 (anti-VEGFC) is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis.

VGX100 (anti-VEGFC) is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis.

VGX100 (anti-VEGFC) is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis.

ApplicationWB: 1/2,000-1/10,000 : Predicted molecular weight: 54 kDaFlow: 0.008 μg/mL – 1 μg/mLICC/IF: 2 μg/mL.